humanitarian

Human medicines European public assessment report (EPAR): Pritor, telmisartan, Date of authorisation: 11/12/1998, Revision: 31, Status: Withdrawn

Human medicines European public assessment report (EPAR): Daybu, trofinetide, Date of authorisation: 20/08/2026, Revision: 1, Status: Authorised

Reported by EMA What Is New Oct 14, 2026 · 10:00 UTC

Read the complete report at EMA What Is New ↗

Verification notice

IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.

INCIDENT FUSION

6 reports · 2 sources

EMA What Is NewHuman medicines European public assessment report (EPAR): Pritor, telmisartan, Date of authorisation: 11/12/1998, Revision: 31, Status: Withdrawn10:00 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Pritor, telmisartan, Date of authorisation: 11/12/1998, Revision: 31, Status: Withdrawn10:00 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Nemluvio, nemolizumab, Date of authorisation: 12/02/2025, Revision: 7, Status: Authorised09:35 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Nemluvio, nemolizumab, Date of authorisation: 12/02/2025, Revision: 7, Status: Authorised09:35 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): mResvia, respiratory syncytial virus mRNA vaccine, Date of authorisation: 22/08/2024, Revision: 11, Status: Authorised09:32 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): mResvia, respiratory syncytial virus mRNA vaccine, Date of authorisation: 22/08/2024, Revision: 11, Status: Authorised09:32 UTC

INCIDENT EVOLUTION

4 recorded states

Oct 14 · 10:41 UTC

Signal first indexedP2 · 99% quality · 2 sources

Oct 14 · 10:45 UTC

Headline updatedP2 · 99% quality · 2 sources

Oct 14 · 11:27 UTC

Source details updatedP2 · 99% quality · 2 sources

Oct 14 · 11:32 UTC

Source details updatedP2 · 99% quality · 2 sources

Explore this day in the archive →